证券之星消息，近日济民健康（维权）披露，截至2025年6月30日公司股东户数为2.81万户，较3月31日 增加388.0户，增幅为1.4%。户均持股数量由上期的1.9万股减少至1.87万股，户均持股市值为12.81万 元。 在医疗器械行业个股中，济民健康股东户数高于行业平均水平，截至6月30日，医疗器械行业平均股东 户数为2.2万户。户均持股市值方面，医疗器械行业A股上市公司户均持股市值为46.49万元，济民健康 低于行业平均水平。 | | | 统计截止日 区间股价涨跌幅 股东户数 增减 增减比例 户均持股市值（元） | | | 户均持股数(股) | | --- | --- | --- | --- | --- | --- | | 2025-06-30 | 13.04% | 28075 388 | 1.40% | 12.81万 | 1.87万 | | 2025-03-31 | -10.75% | 27687 -483 | -1.71% | 11.49万 | 1.90万 | | 2024-12-31 | 2.41% | 28170 -4881 | -14.77% | 12.66万 | 1.86万 | | 2024 ...

Market Overview - The Shanghai Composite Index closed at 3766.21 points, up 1.04%, with a trading volume of 10,175 billion yuan [1] - The Shenzhen Component Index closed at 11,926.74 points, up 0.89%, with a trading volume of 13,907.34 billion yuan [1] - The ChiNext Index closed at 2607.65 points, up 0.23%, with a trading volume of 6,505.37 billion yuan [1] - The STAR Market 50 Index closed at 1148.15 points, up 3.23%, with a trading volume of 655 billion yuan [1] - The total trading volume of both markets reached 24,082.34 billion yuan, marking the sixth consecutive trading day above 20,000 billion yuan, although it decreased by 1,801.36 billion yuan compared to the previous trading day [1] Sector Performance - Strong performance was observed in sectors such as electronics, automotive, beauty care, oil and petrochemicals, food and beverage, light industry manufacturing, insurance, and education [3] - Active concepts included cameras, AI glasses, glyphosate, geothermal energy, generators, liquor, AI smartphones, and titanium dioxide [3] - The pharmaceutical and biological, shipbuilding, and gas industries were among the few sectors that experienced declines [3] Fund Flow Analysis - The net outflow of main funds in the Shanghai and Shenzhen markets was 335.7 billion yuan, with the ChiNext experiencing a net outflow of 228.83 billion yuan [4][5] - Among 31 primary industries, 8 sectors saw net inflows, with the telecommunications sector leading at 25.7 billion yuan [5] - The electronics, food and beverage, and beauty care sectors also saw significant net inflows of 21.79 billion yuan, 9.11 billion yuan, and 2.02 billion yuan, respectively [5] - The computer industry had the highest net outflow at 96.86 billion yuan, followed by pharmaceuticals, machinery, non-bank financials, and power equipment [5] Individual Stock Performance - A total of 2037 stocks experienced net inflows, with 98 stocks receiving over 1 billion yuan in net inflows [6][7] - The stock with the highest net inflow was Inspur Information, with 21.36 billion yuan, followed by ZTE, Guangxun Technology, and others [7] - Conversely, 3102 stocks faced net outflows, with 172 stocks seeing over 1 billion yuan in net outflows [8][9] - The stock with the highest net outflow was Dongfang Wealth, with 14.06 billion yuan, followed by Liou Co., Runhe Software, and others [9] Institutional Activity - Institutional investors had a net sell of approximately 7.18 billion yuan, with 11 stocks seeing net purchases and 21 stocks net sold [10] - The stock with the highest net purchase by institutions was Liou Co., with about 4.71 billion yuan, followed by others like Jiu Gui Jiu and Zhongdian Xindong [10]

二、经营业绩风险 证券代码：603222 证券简称：济民健康 公告编号：2025-039 济民健康管理股份有限公司 股票交易风险提示公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 济民健康管理股份有限公司（以下简称"公司"）股票自 2025 年 8 月 13 日 至 2025 年 8 月 19 日，公司股票收盘价格累计涨幅达 53.78%，并连续两次触及异 动。2025 年 8 月 20 日，公司股票再次涨停，换手率达到 31.31%，上述指标均远 高于行业同期平均水平。公司基本面未发生重大变化，存在市场情绪过热及非理 性炒作的情形，公司股票击鼓传花效应明显，存在较大交易风险，公司股价短期 涨幅较大，后续股票可能存在较大下跌风险。公司郑重提醒广大投资者注意投资 风险，理性决策、审慎投资。 一、二级市级交易风险 自2025年8月13日至2025年8月19日，公司股票收盘价格累计涨幅达53.78%， 并连续两次触及异动。2025 年 8 月 20 日，公司股票再次涨停，换手率达到 31.31%， 上述指标均远高于行业同 ...

经济观察网 济民健康（603222）公告，公司股票自2025年8月13日至2025年8月19日，收盘价格累计涨 幅达53.78%，并连续两次触及异动。2025年8月20日，公司股票再次涨停，换手率达到31.31%。公司基 本面未发生重大变化，存在市场情绪过热及非理性炒作的情形，公司股票击鼓传花效应明显，存在较大 交易风险。同时，2024年度公司净利润为-5971.17万元，2025年半年度预计净利润为-5500万元至-4600 万元，将出现亏损。 ...

济民健康(603222)今日涨停，全天换手率31.31%，成交额18.28亿元，振幅19.56%。龙虎榜数据显示， 营业部席位合计净买入6344.57万元。 上交所公开信息显示，当日该股因日振幅值达19.56%、日换手率达31.31%上榜，营业部席位合计净买 入6344.57万元。 | 买/ | 会员营业部名称 | 买入金额（万 | 卖出金额（万 | | --- | --- | --- | --- | | | | 元） | 元） | | 买一 | 国泰海通证券股份有限公司总部 | 6791.60 | | | | 摩根大通证券(中国)有限公司上海银城中路证券营业部 | 5517.14 | | | 买三 | 高盛(中国)证券有限责任公司上海浦东新区世纪大道证券 营业部 | 3992.07 | | | 卖 买二 | | | | 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交4.08亿元，其中，买入成交额为2.36亿 元，卖出成交额为1.72亿元，合计净买入6344.57万元。 具体来看，今日上榜营业部中，第一大买入营业部为国泰海通证券股份有限公司总部，买入金额为 6791.60万元，第一大卖出营业部为浙商 ...

Core Insights - The A-share market is experiencing a significant rally, with the Shanghai Composite Index reaching a nearly ten-year high of 3767 points, driven by increased trading volumes and investor confidence [1][3][9] - A notable shift in capital flows is observed, with a decrease of 1.1 trillion yuan in household deposits and a rise of 2.14 trillion yuan in non-bank deposits, indicating a movement of savings into the stock market [1][9] - The total market capitalization of A-shares has surpassed 100 trillion yuan for the first time, reflecting strong market sentiment and participation [3][9] Market Performance - On August 20, the A-share market saw a total trading volume of 2.41 trillion yuan, maintaining high activity levels despite a slight decrease from August 18 [1] - The market is characterized by a broad-based rally, with over 3600 stocks rising and 86 stocks hitting the daily limit-up [6][9] - The financial sector has been a standout performer, with significant gains in key stocks such as Zhongjin and Tonghuashun, indicating strong investor interest [7][9] Economic and Policy Factors - The current bull market is supported by multiple favorable factors, including a steady recovery in the Chinese economy, improved export data, and supportive monetary policies from the central bank [9] - The People's Bank of China has maintained liquidity through measures such as interest rate cuts, which have encouraged investment in the stock market [9] - Global monetary easing, particularly anticipated rate cuts by the Federal Reserve, has made A-shares attractive to international investors [9] Historical Context - The recent surge in margin trading balances, which have exceeded 2 trillion yuan, draws comparisons to the 2015 bull market, but experts note significant differences in market conditions and regulatory environments [10][15] - Unlike the rapid and speculative nature of the 2015 market, the current environment is described as a "slow bull" with stricter controls on leverage, contributing to greater market stability [10][15] Investor Sentiment and Behavior - The current market enthusiasm is reminiscent of previous bull markets, with widespread optimism among retail investors and increased marketing efforts from brokerage firms [4][6] - However, there are warnings about potential risks associated with high valuations and increased leverage, which could lead to market volatility if sentiment shifts [12][15] - Investors are advised to maintain a rational approach, focusing on quality stocks and avoiding excessive speculation or leverage [15]

Core Viewpoint - Jimin Health (603222.SH) reported a significant decline in revenue and incurred losses in the first half of the year, primarily due to external factors and inventory adjustments [1] Financial Performance - The company achieved total operating revenue of 366.44 million yuan, a decrease of 21.30% compared to the same period last year [1] - The medical services segment generated revenue of 168.62 million yuan, down 4.80% year-on-year [1] - The medical device segment reported revenue of 75.10 million yuan, a substantial decline of 47.54% year-on-year [1] - The large-volume infusion segment earned revenue of 121.35 million yuan, reflecting a decrease of 15.50% year-on-year [1] Profitability - The company recorded a net loss attributable to shareholders of 52.70 million yuan and a net loss of 53.20 million yuan after excluding non-recurring gains and losses [1] - The losses were primarily attributed to the impact of U.S. tariff policies and the "He Qinghong stamp incident," which significantly reduced revenue and profits from medical devices [1] - Additionally, the company increased inventory write-down provisions for pre-filled catheter flushing devices and safety syringes based on market sales conditions [1]

济民健康管理股份有限公司2025 年半年度报告 公司代码：603222 公司简称：济民健康 济民健康管理股份有限公司 2025 年半年度报告 1 / 155 济民健康管理股份有限公司2025 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确 性、完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 公司全体董事出席董事会会议。 三、 本半年度报告未经审计。 四、 公司负责人李丽莎、主管会计工作负责人杨国伟及会计机构负责人（会计主管人员）王合 微声明：保证半年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 报告期，公司不进行利润分配及资本公积转增股本。 六、 前瞻性陈述的风险声明 √适用 □不适用 本报告中所涉及的未来计划、发展战略等前瞻性陈述，不构成公司对投资者的实质承诺，敬 请投资者注意投资风险。 七、 是否存在被控股股东及其他关联方非经营性占用资金情况 否 八、 是否存在违反规定决策程序对外提供担保的情况 否 九、 是否存在半数以上董事无法保证公司所披露半年度报告的 ...

济民健康公告，2025年上半年营业收入3.66亿元，同比下降21.30%。净利润亏损5269.59万元，上年同 期净利润2544.5万元。报告期，公司不进行利润分配及资本公积转增股本。 ...

证券之星消息，8月20日医疗器械板块较上一交易日上涨0.06%，济民健康领涨。当日上证指数报收于 3766.21，上涨1.04%。深证成指报收于11926.74，上涨0.89%。医疗器械板块个股涨跌见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 603222 | 济民健康 | 11.86 | 10.02% | 164.39万 | | 18.28亿 | | 300642 | 透景生命 | 24.81 | 7.45% | 35.17万 | | 8.65 Z | | 688581 | 安杰思 | 87.93 | 6.07% | 2.57万 | | 2.20亿 | | 301093 | 华兰股份 | 34.04 | 4.58% | 13.19万 | | 4.45亿 | | 600645 | 中源协和 | 29.66 | 3.27% | 23.37万 | | ...